Neurosonix Wins Major European Cardiac Surgery Innovation Award

REHOVOT, Israel--(BUSINESS WIRE)--Neurosonix Ltd., an Israeli company that developed non-invasive ultrasound-based embolic protection technologies for use in cardiac surgery and cath lab practice, is pleased to announce receiving the European Association of Cardio-Thoracic Surgery Techno-College Innovation Award for its first device, the EmBlocker™. This prestigious award was established to honor technological breakthroughs in all areas related to thoracic and cardiovascular research. The award was announced at a ceremony at the Annual Techno-College in Geneva, in front of an audience of over a 1,000 leading cardiac surgeons from around the world.